ANAVEX LIFE SCIENCES CORP.
Company Information
Industry
Biological Products, (No Diagnostic Substances)
SIC Code
2836
Entity Type
operating
SEC Category
Large accelerated filer
Business Address
630 5TH AVENUE, NEW YORK, NY, 10111
Mailing Address
630 5TH AVENUE, NEW YORK, NY, 10111
Phone
844-689-3939
Fiscal Year End
0930
EIN
980608404
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| 8-K Current report of material events | February 9, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 4 Insider stock transaction report | January 9, 2026 | View on SEC |
| 10-K Annual financial report | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 25, 2025 | View on SEC |
| 8-K Current report of material events | November 14, 2025 | View on SEC |
Annual Reports
10-K
November 25, 2025
- Recognized by the SEC as a "well-known seasoned issuer" and "large accelerated filer" with strong internal controls and timely reporting.
- Market value of shares held by regular investors was approximately $708 million as of March 31, 2025, with 89.3 million common shares outstanding by November 24, 2025.
Material Events
8-K
Strategy Change
March 25, 2026
High Impact
- Strategic withdrawal of EU marketing application to avoid formal rejection
- Pivot to U.S. FDA regulatory pathway for blarcamesine
Related Companies
Companies in the same industry (SIC: 2836)
MESOBLAST LTD
MESO
Biological Products, (No Diagnostic Substances)
Quince Therapeutics, Inc.
QNCX
Biological Products, (No Diagnostic Substances)
Kymera Therapeutics, Inc.
KYMR
Biological Products, (No Diagnostic Substances)
Scilex Holding Co
SCLX
Biological Products, (No Diagnostic Substances)
Vor Biopharma Inc.
VOR
Biological Products, (No Diagnostic Substances)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.